IV 
113TH CONGRESS 
2D SESSION 
H. RES. 688 
Supporting the role of the United States in ensuring children in poor countries 
have access to vaccines and immunization through the GAVI Alliance. 
IN THE HOUSE OF REPRESENTATIVES 
JULY 25, 2014 
Ms. MCCOLLUM (for herself, Mr. REICHERT, Mr. ENGEL, Mr. CRENSHAW, 
Ms. BASS, Mr. DIAZ-BALART, Ms. LEE of California, Mr. FITZPATRICK, 
Mr. SMITH of Washington, Mr. MCCAUL, Ms. ESTY, Mr. MCHENRY, Ms. 
SPEIER, Mr. ROSS, Mr. MCDERMOTT, Mr. HALL, Mr. LEVIN, Mr. 
SCHOCK, and Ms. ROYBAL-ALLARD) submitted the following resolution; 
which was referred to the Committee on Foreign Affairs 
RESOLUTION 
Supporting the role of the United States in ensuring children 
in poor countries have access to vaccines and immuniza-
tion through the GAVI Alliance. 
Whereas prior to 2000, the distribution of and the resources 
for vaccines for children in the developing world were de-
clining, immunization rates were stagnant or decreasing 
and nearly 30,000,000 children born in the developing 
world each year were not fully immunized; 
Whereas prior to 2000, it was common for new life-saving 
vaccines to take up to 15 years to be introduced in the 
world’s poorest countries; 
VerDate Mar 15 2010 
00:58 Jul 26, 2014
Jkt 039200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6300
E:\BILLS\HR688.IH
HR688
tjames on DSK5VPTVN1PROD with BILLS
•HRES 688 IH 
Whereas access to routine immunization and vaccines protect 
children from deadly but preventable disease and con-
tribute to national economic growth and poverty reduc-
tion by ensuring people live longer, healthier, and more 
productive lives; 
Whereas in 2000, the Bill & Melinda Gates Foundation, the 
United States, the United Nations Children’s Emergency 
Fund (UNICEF), the World Health Organization, the 
World Bank, bilateral partners, developing countries, the 
private sector, including the vaccine industry, civil soci-
ety, and other partners joined forces to create a public- 
private partnership called the Global Fund for Children’s 
Vaccine (now the GAVI Alliance) in order to expand ac-
cess to new and underused vaccines and support the in-
troduction and scale-up of these vaccines into routine im-
munization systems in the world’s poorest countries; 
Whereas partnership and sustainability are at the core of the 
GAVI Alliance model by requiring GAVI-eligible countries 
to contribute financing to some portion of their vaccine 
costs and directly invest in immunizing their children; 
Whereas by 2012, more than 65 developing countries working 
with the GAVI Alliance were co-financing new and 
underused vaccines funded by the GAVI Alliance and 
more than 20 countries are projected to graduate be-
tween 2016 and 2020, moving toward fully funding their 
national immunization programs; 
Whereas the GAVI Alliance has transformed the market for 
vaccines by pooling demand from developing countries 
matched with secure, predictable financing to make vac-
cines more affordable and supply more reliable, and en-
couraging research and development of new vaccines; 
VerDate Mar 15 2010 
00:58 Jul 26, 2014
Jkt 039200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6300
E:\BILLS\HR688.IH
HR688
tjames on DSK5VPTVN1PROD with BILLS